ArticleJournal of asthma and allergy2024

Benralizumab: Effectiveness in Patients with Uncontrolled Severe Eosinophilic Asthma at 6 and 12 Months at a Third-Level Care Hospital. Capacity for ICS-LABA Therapy Reduction.

Yair Humberto González-Tuyub et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.